Modulation of acetylcholine receptor by antibody against the receptor
- PMID: 268657
- PMCID: PMC431419
- DOI: 10.1073/pnas.74.7.3090
Modulation of acetylcholine receptor by antibody against the receptor
Abstract
Antibody against acetylcholine receptor induces an increase in the rate of degradation of acetylcholine receptors on a mouse cell line (BC(3)H-1) and cultured rat skeletal muscle. The increased rate of degradation results in a lowered density of acetylcholine receptors on muscle membrane and a lowered sensitivity to iontophoretically applied acetylcholine. The modulation of acetylcholine receptor is energy, temperature, and time dependent and may be related to antigenic modulation found in other systems. Acetylcholine noise analysis demonstrates that antibody against acetylcholine receptor reduces the channel mean conductance and mean open time slightly. It is concluded that antibody binds to the acetylcholine receptor, impairs its function, and induces receptor degradation. This results in a lowered density of acetylcholine receptor and a lowered sensitivity to acetylcholine. Patients with myasthenia gravis have antibodies to their acetylcholine receptor in their serum. Antigenic modulation of receptor in the muscle of patients with myasthenia gravis could contribute to the observed decrease in amplitudes of miniature endplate potentials and in muscle acetylcholine sensitivity, and the symptoms of muscular weakness.
Similar articles
-
Accelerated degradation of acetylcholine receptor from cultured rat myotubes with myasthenia gravis sera and globulins.Proc Natl Acad Sci U S A. 1977 May;74(5):2130-4. doi: 10.1073/pnas.74.5.2130. Proc Natl Acad Sci U S A. 1977. PMID: 266734 Free PMC article.
-
Antibody to acetylcholine receptor increases degradation of junctional and extrajunctional receptors in adult muscle.Nature. 1978 Jul 6;274(5666):68-70. doi: 10.1038/274068a0. Nature. 1978. PMID: 661996 No abstract available.
-
Antigenic modulation and receptor loss in experimental autoimmune myasthenia gravis.Muscle Nerve. 1979 May-Jun;2(3):173-9. doi: 10.1002/mus.880020304. Muscle Nerve. 1979. PMID: 503104
-
Characterization of a putative nicotinic acetylcholine receptor in mammalian brain.Brain Res. 1981 Aug;228(1):81-104. doi: 10.1016/0165-0173(81)90013-8. Brain Res. 1981. PMID: 7023616 Review. No abstract available.
-
Serum acetylcholine-receptor antibodies in myasthenia gravis.Ann N Y Acad Sci. 1976;274:235-43. doi: 10.1111/j.1749-6632.1976.tb47689.x. Ann N Y Acad Sci. 1976. PMID: 786109 Review. No abstract available.
Cited by
-
The main immunogenic region (MIR) of the nicotinic acetylcholine receptor and the anti-MIR antibodies.Mol Neurobiol. 1991 Spring;5(1):1-29. doi: 10.1007/BF02935610. Mol Neurobiol. 1991. PMID: 1725702 Review.
-
Role of complement and potential of complement inhibitors in myasthenia gravis and neuromyelitis optica spectrum disorders: a brief review.J Neurol. 2021 May;268(5):1643-1664. doi: 10.1007/s00415-019-09498-4. Epub 2019 Sep 3. J Neurol. 2021. PMID: 31482201 Review.
-
Myasthenia Gravis: Pathogenic Effects of Autoantibodies on Neuromuscular Architecture.Cells. 2019 Jul 2;8(7):671. doi: 10.3390/cells8070671. Cells. 2019. PMID: 31269763 Free PMC article. Review.
-
Autoimmune myasthenia gravis: emerging clinical and biological heterogeneity.Lancet Neurol. 2009 May;8(5):475-90. doi: 10.1016/S1474-4422(09)70063-8. Lancet Neurol. 2009. PMID: 19375665 Free PMC article. Review.
-
Immunological distinction between acetylcholine receptor and the alpha-bungarotoxin-binding component on sympathetic neurons.Proc Natl Acad Sci U S A. 1977 Oct;74(10):4689-92. doi: 10.1073/pnas.74.10.4689. Proc Natl Acad Sci U S A. 1977. PMID: 270708 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources